1. Home
  2. BPT vs NERV Comparison

BPT vs NERV Comparison

Compare BPT & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPT
  • NERV
  • Stock Information
  • Founded
  • BPT 1989
  • NERV 2007
  • Country
  • BPT United States
  • NERV United States
  • Employees
  • BPT N/A
  • NERV N/A
  • Industry
  • BPT Integrated oil Companies
  • NERV Biotechnology: Pharmaceutical Preparations
  • Sector
  • BPT Energy
  • NERV Health Care
  • Exchange
  • BPT Nasdaq
  • NERV Nasdaq
  • Market Cap
  • BPT 22.3M
  • NERV 18.3M
  • IPO Year
  • BPT N/A
  • NERV 2014
  • Fundamental
  • Price
  • BPT $0.65
  • NERV $2.19
  • Analyst Decision
  • BPT
  • NERV Hold
  • Analyst Count
  • BPT 0
  • NERV 1
  • Target Price
  • BPT N/A
  • NERV $5.00
  • AVG Volume (30 Days)
  • BPT 301.1K
  • NERV 14.3K
  • Earning Date
  • BPT 12-27-2024
  • NERV 11-05-2024
  • Dividend Yield
  • BPT N/A
  • NERV N/A
  • EPS Growth
  • BPT N/A
  • NERV N/A
  • EPS
  • BPT N/A
  • NERV N/A
  • Revenue
  • BPT $257,000.00
  • NERV N/A
  • Revenue This Year
  • BPT N/A
  • NERV N/A
  • Revenue Next Year
  • BPT N/A
  • NERV N/A
  • P/E Ratio
  • BPT N/A
  • NERV N/A
  • Revenue Growth
  • BPT N/A
  • NERV N/A
  • 52 Week Low
  • BPT $0.61
  • NERV $2.06
  • 52 Week High
  • BPT $3.25
  • NERV $13.49
  • Technical
  • Relative Strength Index (RSI)
  • BPT 30.02
  • NERV 45.26
  • Support Level
  • BPT $0.61
  • NERV $2.08
  • Resistance Level
  • BPT $0.71
  • NERV $2.32
  • Average True Range (ATR)
  • BPT 0.10
  • NERV 0.13
  • MACD
  • BPT -0.02
  • NERV 0.01
  • Stochastic Oscillator
  • BPT 7.87
  • NERV 33.33

About BPT BP Prudhoe Bay Royalty Trust

BP Prudhoe Bay Royalty Trust is a grantor trust operating in the US. The property of the Trust consists of an overriding royalty interest. The Royalty Interest entitles the Trust to receive the royalty from the production of crude oil and condensate from the working interest of BP Exploration (Alaska) Inc. in the Prudhoe Bay oil field located on the North Slope of Alaska.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: